View in EDS HTML Full Text PDF Full Text

Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).

Saved in:
Bibliographic Details
Title: Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Authors: Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan., Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, 944-25 Fujita, Kato, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Japan., Ishiguro N, Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan., Westhovens R; Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Division of Rheumatology, University Hospitals KU Leuven, Leuven, Belgium., Ching DWT; Timaru Medical Specialists Limited, South Canterbury, New Zealand., Messina OD; Investigaciones Reumatologicas y Osteologicas SRL IRO, Buenos Aires, Argentina., Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University, Berlin, Germany., Bartok B; Gilead Sciences Inc., Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc., Foster City, CA, USA., Kondo A; Gilead Sciences K.K., Tokyo, Japan., Yin Z; Gilead Sciences Inc., Foster City, CA, USA., Guo Y; Gilead Sciences Inc., Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences Inc., Foster City, CA, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Aichi Developmental Disability Center, Kasugai, Japan., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Source: Modern rheumatology [Mod Rheumatol] 2022 Feb 28; Vol. 32 (2), pp. 273-283.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34910203
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Atsumi+T%22">Atsumi T</searchLink>; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.<br /><searchLink fieldCode="AU" term="%22Matsubara+T%22">Matsubara T</searchLink>; Department of Orthopedics, Matsubara Mayflower Hospital, 944-25 Fujita, Kato, Japan.<br /><searchLink fieldCode="AU" term="%22Amano+K%22">Amano K</searchLink>; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ishiguro+N%22">Ishiguro N</searchLink><br /><searchLink fieldCode="AU" term="%22Sugiyama+E%22">Sugiyama E</searchLink>; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaoka+K%22">Yamaoka K</searchLink>; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.<br /><searchLink fieldCode="AU" term="%22Westhovens+R%22">Westhovens R</searchLink>; Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Division of Rheumatology, University Hospitals KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Ching+DWT%22">Ching DWT</searchLink>; Timaru Medical Specialists Limited, South Canterbury, New Zealand.<br /><searchLink fieldCode="AU" term="%22Messina+OD%22">Messina OD</searchLink>; Investigaciones Reumatologicas y Osteologicas SRL IRO, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Burmester+GR%22">Burmester GR</searchLink>; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bartok+B%22">Bartok B</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pechonkina+A%22">Pechonkina A</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kondo+A%22">Kondo A</searchLink>; Gilead Sciences K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yin+Z%22">Yin Z</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tasset+C%22">Tasset C</searchLink>; Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Sundy+JS%22">Sundy JS</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Aichi Developmental Disability Center, Kasugai, Japan.<br /><searchLink fieldCode="AU" term="%22Takeuchi+T%22">Takeuchi T</searchLink>; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100959226%22">Modern rheumatology</searchLink> [Mod Rheumatol] 2022 Feb 28; Vol. 32 (2), pp. 273-283.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100959226 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1439-7609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214397595%22">14397595 </searchLink><i>NLM ISO Abbreviation: </i>Mod Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34910203
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/mr/roab021
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 273
    Titles:
      – TitleFull: Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Atsumi T
      – PersonEntity:
          Name:
            NameFull: Tanaka Y
      – PersonEntity:
          Name:
            NameFull: Matsubara T
      – PersonEntity:
          Name:
            NameFull: Amano K
      – PersonEntity:
          Name:
            NameFull: Ishiguro N
      – PersonEntity:
          Name:
            NameFull: Sugiyama E
      – PersonEntity:
          Name:
            NameFull: Yamaoka K
      – PersonEntity:
          Name:
            NameFull: Westhovens R
      – PersonEntity:
          Name:
            NameFull: Ching DWT
      – PersonEntity:
          Name:
            NameFull: Messina OD
      – PersonEntity:
          Name:
            NameFull: Burmester GR
      – PersonEntity:
          Name:
            NameFull: Bartok B
      – PersonEntity:
          Name:
            NameFull: Pechonkina A
      – PersonEntity:
          Name:
            NameFull: Kondo A
      – PersonEntity:
          Name:
            NameFull: Yin Z
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Tasset C
      – PersonEntity:
          Name:
            NameFull: Sundy JS
      – PersonEntity:
          Name:
            NameFull: Takeuchi T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2022 Feb 28
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1439-7609
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Modern rheumatology
              Type: main
ResultId 1